MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Exploring the link between HPV and head and neck cancers

Release issued 11th June 2009

The link between cervical cancer and the Human Papilloma Virus (HPV) is well accepted, but a leading researcher from the Ohio University Comprehensive Cancer Centre says HPV is also linked to other cancers including oral cancer.

Dr. Maura Gillison will present a lecture titled "The impact of HPV on prevention, screening and treatment of head and neck cancers" as part of the Sixth Annual Research & Education Day by the Department of Oncology at Western's Schulich School of Medicine & Dentistry.

The full-day event, scheduled for Friday (June 12) at the Best Western Lamplighter Inn, is sponsored by Schulich, the London Regional Cancer Program at London Health Sciences Centre and the Canadian Institutes of Health Research (CIHR).

Oncology Research & Education Day is organized by the CIHR-Strategic Training Program in Cancer Research and Technology Transfer (CaRTT). Principal investigator, Dr. Jim Koropatnick is pleased that CaRTT has recently been renewed for funding for six years (2009-2015) from the CIHR.

A total of $3,759,600 ($1,950,000 from the CIHR and $1,809,600 from Western and the Lawson Health Research Institute) will continue support of a comprehensive cancer research training program that spans basic science and medicine, and multiple research disciplines, all focused on making a difference in the lives of Canadians before, during, and after their experience with cancer.

 

Company details

If you want to find out more about the company visit WORLDiscoveries profile.

Latest WORLDiscoveries press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Profile your company today
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us